{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T18:40:17Z","timestamp":1772563217617,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002632","name":"Hallym University","doi-asserted-by":"publisher","award":["HURF-2014-11"],"award-info":[{"award-number":["HURF-2014-11"]}],"id":[{"id":"10.13039\/501100002632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Malignant pleural effusion (MPE) causes substantial symptomatic burden in advanced malignancy. Although pleural fluid cytology is a commonly accepted gold standard of diagnosis, its low diagnostic yield is a challenge for clinicians. The aim of this study was to determine whether pro-cathepsin D can serve as a novel biomarker to discriminate between MPE and benign pleural effusion (BPE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study included 81 consecutive patients with exudative pleural effusions who had underwent thoracentesis or pleural biopsy. Pleural fluid and serum were collected as a standard procedure for all individuals at the same time. The level of pro-cathepsin D was measured by the sandwich enzyme-linked immunosorbent assay method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Though there were no significant differences in plasma pro-cathepsin D between the two groups, the level of pleural fluid pro-cathepsin D was significantly higher in the MPE group than the BPE group (0.651 versus 0.590\u2009pg\/mL,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.034). The discriminative power of pleural fluid pro-cathepsin D for diagnosing MPE was moderate, with 81% sensitivity and 53% specificity at a pro-cathepsin D cut-off \u22650.596\u2009pg\/mL (area under the curve: 0.656). Positive and negative predictive values for MPE were 38 and 89%, respectively, with pro-cathepsin D cut-off value (&gt;\u20090.596\u2009pg\/mL).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The level of pleural fluid pro-cathepsin D was found to be significantly higher in MPE than in BPE. Although results of this study could not support the sole use of pleural fluid pro-cathepsin D to diagnose MPE, pleural fluid pro-cathepsin D can be added to pre-existing diagnostic methods for ruling-in or ruling-out MPE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-07327-w","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T06:03:10Z","timestamp":1598853790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study"],"prefix":"10.1186","volume":"20","author":[{"given":"Hayoung","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousang","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4088-4993","authenticated-orcid":false,"given":"Chang Youl","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,31]]},"reference":[{"issue":"140","key":"7327_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1183\/16000617.0019-2016","volume":"25","author":"I Psallidas","year":"2016","unstructured":"Psallidas I, Kalomenidis I, Porcel JM, Robinson BW, Stathopoulos GT. Malignant pleural effusion: from bench to bedside. Eur Respir Rev. 2016;25(140):189\u201398.","journal-title":"Eur Respir Rev"},{"issue":"2","key":"7327_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00408-012-9445-1","volume":"191","author":"JA Kastelik","year":"2013","unstructured":"Kastelik JA. Management of malignant pleural effusion. Lung. 2013;191(2):165\u201375.","journal-title":"Lung."},{"issue":"7","key":"7327_CR3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1164\/rccm.201807-1415ST","volume":"198","author":"DJ Feller-Kopman","year":"2018","unstructured":"Feller-Kopman DJ, Reddy CB, DeCamp MM, Diekemper RL, Gould MK, Henry T, et al. Management of Malignant Pleural Effusions. An official ATS\/STS\/STR clinical practice guideline. Am J Respir Crit Care Med. 2018;198(7):839\u201349.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"7327_CR4","first-page":"235","volume":"50","author":"V Villena Garrido","year":"2014","unstructured":"Villena Garrido V, Cases Viedma E, Fernandez Villar A, de Pablo GA, Perez Rodriguez E, Porcel Perez JM, et al. Recommendations of diagnosis and treatment of pleural effusion. Update Arch Bronconeumol. 2014;50(6):235\u201349.","journal-title":"Update Arch Bronconeumol"},{"issue":"1","key":"7327_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00408-015-9831-6","volume":"194","author":"A Verma","year":"2016","unstructured":"Verma A, Abisheganaden J, Light RW. Identifying malignant pleural effusion by a cancer ratio (serum LDH: pleural fluid ADA ratio). Lung. 2016;194(1):147\u201353.","journal-title":"Lung."},{"issue":"2","key":"7327_CR6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.21037\/jtd.2018.12.136","volume":"11","author":"SB Reuter","year":"2019","unstructured":"Reuter SB, Clementsen PF, Bodtger U. Incidence of malignancy and survival in patients with idiopathic pleuritis. J Thorac Dis. 2019;11(2):386\u201392.","journal-title":"J Thorac Dis"},{"key":"7327_CR7","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.2147\/OTT.S157551","volume":"11","author":"WW Wang","year":"2018","unstructured":"Wang WW, Zhou XL, Song YJ, Yu CH, Zhu WG, Tong YS. Combination of long noncoding RNA MALAT1 and carcinoembryonic antigen for the diagnosis of malignant pleural effusion caused by lung cancer. Onco Targets Ther. 2018;11:2333\u201344.","journal-title":"Onco Targets Ther"},{"issue":"2","key":"7327_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10147-016-1073-y","volume":"22","author":"M Feng","year":"2017","unstructured":"Feng M, Zhu J, Liang L, Zeng N, Wu Y, Wan C, et al. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis. Int J Clin Oncol. 2017;22(2):283\u201390.","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"7327_CR9","first-page":"00034","volume":"2","author":"V Vetvicka","year":"2016","unstructured":"Vetvicka V. Procathepsin D: new target for treating cancer. Int Clin Pathol J. 2016;2(2):00034.","journal-title":"Int Clin Pathol J"},{"issue":"5","key":"7327_CR10","first-page":"1223","volume":"30","author":"A Vashishta","year":"2007","unstructured":"Vashishta A, Ohri SS, Proctor M, Fusek M, Vetvicka V. Ribozyme-targeting procathepsin D and its effect on invasion and growth of breast cancer cells: an implication in breast cancer therapy. Int J Oncol. 2007;30(5):1223\u201330.","journal-title":"Int J Oncol"},{"issue":"1","key":"7327_CR11","first-page":"47","volume":"31","author":"V Vetvicka","year":"2011","unstructured":"Vetvicka V, Vetvickova J. Procathepsin D and cytokines influence the proliferation of lung cancer cells. Anticancer Res. 2011;31(1):47\u201351.","journal-title":"Anticancer Res"},{"issue":"2\u20133","key":"7327_CR12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/pmic.201300226","volume":"14","author":"YJ Qi","year":"2014","unstructured":"Qi YJ, Ward DG, Pang C, Wang QM, Wei W, Ma J, et al. Proteomic profiling of N-linked glycoproteins identifies ConA-binding procathepsin D as a novel serum biomarker for hepatocellular carcinoma. Proteomics. 2014;14(2\u20133):186\u201395.","journal-title":"Proteomics."},{"issue":"5","key":"7327_CR13","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1164\/ajrccm.162.5.ats8-00","volume":"162","author":"American Thoracic S","year":"2000","unstructured":"American Thoracic S. Management of malignant pleural effusions. Am J Respir Crit Care Med. 2000;162(5):1987\u20132001.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"7327_CR14","doi-asserted-by":"publisher","first-page":"e0165428","DOI":"10.1371\/journal.pone.0165428","volume":"11","author":"H Choi","year":"2016","unstructured":"Choi H, Chon HR, Kim K, Kim S, Oh KJ, Jeong SH, et al. Clinical and laboratory differences between lymphocyte- and neutrophil-predominant pleural tuberculosis. PLoS One. 2016;11(10):e0165428.","journal-title":"PLoS One"},{"issue":"9","key":"7327_CR15","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1136\/thoraxjnl-2011-201363","volume":"67","author":"SY Ruan","year":"2012","unstructured":"Ruan SY, Chuang YC, Wang JY, Lin JW, Chien JY, Huang CT, et al. Revisiting tuberculous pleurisy: pleural fluid characteristics and diagnostic yield of mycobacterial culture in an endemic area. Thorax. 2012;67(9):822\u20137.","journal-title":"Thorax."},{"issue":"1","key":"7327_CR16","first-page":"19","volume":"41","author":"KC Ong","year":"2000","unstructured":"Ong KC, Indumathi V, Poh WT, Ong YY. The diagnostic yield of pleural fluid cytology in malignant pleural effusions. Singap Med J. 2000;41(1):19\u201323.","journal-title":"Singap Med J"},{"issue":"1","key":"7327_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.critrevonc.2008.02.008","volume":"68","author":"P Benes","year":"2008","unstructured":"Benes P, Vetvicka V, Fusek M. Cathepsin D--many functions of one aspartic protease. Crit Rev Oncol Hematol. 2008;68(1):12\u201328.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"7327_CR18","first-page":"235","volume":"12","author":"G Leto","year":"1992","unstructured":"Leto G, Gebbia N, Rausa L, Tumminello FM. Cathepsin D in the malignant progression of neoplastic diseases (review). Anticancer Res. 1992;12(1):235\u201340.","journal-title":"Anticancer Res"},{"issue":"23","key":"7327_CR19","doi-asserted-by":"crossref","first-page":"13403","DOI":"10.1016\/S0021-9258(18)80010-2","volume":"264","author":"S Diment","year":"1989","unstructured":"Diment S, Martin KJ, Stahl PD. Cleavage of parathyroid hormone in macrophage endosomes illustrates a novel pathway for intracellular processing of proteins. J Biol Chem. 1989;264(23):13403\u20136.","journal-title":"J Biol Chem"},{"issue":"10","key":"7327_CR20","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.4049\/jimmunol.141.10.3313","volume":"141","author":"J Puri","year":"1988","unstructured":"Puri J, Factorovich Y. Selective inhibition of antigen presentation to cloned T cells by protease inhibitors. J Immunol. 1988;141(10):3313\u20137.","journal-title":"J Immunol"},{"issue":"2","key":"7327_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1023\/B:CLIN.0000024740.44602.b7","volume":"21","author":"G Leto","year":"2004","unstructured":"Leto G, Tumminello FM, Crescimanno M, Flandina C, Gebbia N. Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications. Clin Exp Metastasis. 2004;21(2):91\u2013106.","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"7327_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1699-0463.1999.tb01530.x","volume":"107","author":"H Rochefort","year":"1999","unstructured":"Rochefort H, Liaudet-Coopman E. Cathepsin D in cancer metastasis: a protease and a ligand. APMIS. 1999;107(1):86\u201395.","journal-title":"APMIS."},{"issue":"1","key":"7327_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4103\/0301-4738.37595","volume":"56","author":"R Parikh","year":"2008","unstructured":"Parikh R, Mathai A, Parikh S, Chandra Sekhar G, Thomas R. Understanding and using sensitivity, specificity and predictive values. Indian J Ophthalmol. 2008;56(1):45\u201350.","journal-title":"Indian J Ophthalmol"},{"issue":"38","key":"7327_CR24","doi-asserted-by":"publisher","first-page":"5951","DOI":"10.1038\/sj.onc.1205745","volume":"21","author":"G Berchem","year":"2002","unstructured":"Berchem G, Glondu M, Gleizes M, Brouillet JP, Vignon F, Garcia M, et al. Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene. 2002;21(38):5951\u20135.","journal-title":"Oncogene."},{"issue":"2","key":"7327_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.canlet.2005.06.007","volume":"237","author":"E Liaudet-Coopman","year":"2006","unstructured":"Liaudet-Coopman E, Beaujouin M, Derocq D, Garcia M, Glondu-Lassis M, Laurent-Matha V, et al. Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis. Cancer Lett. 2006;237(2):167\u201379.","journal-title":"Cancer Lett"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07327-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07327-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07327-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T11:07:50Z","timestamp":1696590470000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07327-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,31]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7327"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07327-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.20784\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.20784\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.20784\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.20784\/v4","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,31]]},"assertion":[{"value":"27 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study protocol was approved by the Institutional Review Board at Hallym University, and written informed consent was obtained from all patients (application no. 2014\u201318).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"825"}}